Shanghai Junshi Biosciences Breast Cancer Drug Obtains DRC From NMPA; Shares Jump 8%
Shanghai Junshi Biosciences Breast Cancer Drug Obtains DRC From NMPA; Shares Jump 8%
上海军事生物科技公司的乳腺癌药物获得国家药品监督管理局的药品注册证;股价上涨8%。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册